Page History
...
The FNL staff will communicate with all relevant stakeholders. In addition to ensuring the request system is working, the FNL staff will ensure any questions by requesters are answered, requests are reviewed and all decisions are communicated appropriately and in a timely fashion.
...
Data Governance Advisory Board.
Composed The DGAB is composed of 4 external members (from ICDC Steering Committee), 2 NIH members (1 of which is from CBIIT) and supported by FNL staff. The DGAB will be chaired by a non-NIH member of ICDC Steering Committee. The DGAB will meet at least quarterly to review and adjudicate on all open and complete requests. They will use documented evaluation criteria to determine if a request is approved or declined. The DGAB will also determine the evaluation criteria (which will include considering scientific value of data for the ICDC) and may adjust those criteria. The DGAB is also responsible for providing input on the development and maintenance of data life cycle considerations. The DGAB Chair will be responsible for ensuring each meeting has an agenda, defining if a quorum is present, confirming evaluation criteria are current, and ensuring discussions are unbiased. The DGAB Chair will also report to the ICDC Steering Committee the summary status of all data requests. Since the ICDC is a node in the Cancer Research Data Commons (CRDC), data requests may involve considering other CRDC components (for example, the CRDC-H data model or the Cancer Data Aggregator). The CBIIT representative will be responsible for representing CRDC considerations in discussing requests and in development and maintenance of any relevant evaluation criteria. DGAB meetings will not require in-person attendance. The DGAB may decide, from time-to-time, that reprioritization of studies is necessary and will suggest such changes to the SAC.
...
Study | PI | JIRA # | Status | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | COTC007B | Tomaszewski |
| LoadedData in production. Additional files to be received. | ||||||||||||
2 | NCATS-COP01 | Tawa/LeBlanc |
| 1/5 chohorts loadedData in production. Additional files to be received. | ||||||||||||
3 | Glioma01GLIOMA01 | VerHaak |
| Standardizing DataData in production. Additional files to be received. | ||||||||||||
4 | Bladder Cancer – vemurafenibUBC01 | Knapp |
| StartedUnder embargo. Pending publication. | ||||||||||||
5 | Bladder Cancer – treatment naïveUBC02 | Knapp |
| StartedEmbargo lifted. Article not yet in press. | ||||||||||||
6 | OsteosarcomaOSA01 | Henricks | Not Started |
| Pending final review by submitter. | |||||||||||
7 | OSA02 | Henricks | Changes to case annotations have been recommended to submitter. | |||||||||||||
8 | MGT01 | 7 | CAN-14-0392 | Zhao |
| Final case and sample annotations have been received from the submitter. Preparing for data ingestion. | ||||||||||
9 | CCL01 | Duval | No data yet available. | Not Started